Scientific Affairs

and REVIVE

There is growing alarm over drug resistance, as well as concern over the slow rate in the discovery and development of new antibiotic treatments. Furthermore, the abandonment of antimicrobial (AMR) research and development by many companies and academic laboratories has led to the risk of losing valuable knowledge in the field. To address this risk, GARDP launched REVIVE in January 2018. REVIVE ensures that knowledge is retained and that the antimicrobial R&D community is supported to connect, share, and acquire information.

Programme goals

Cutaneous Leishmaniasis In Pakistan: Patient Testimonies
Goal 1

Facilitate learning and knowledge exchange

Goal 2
Goal 2

Connect the antimicrobial R&D and AMR communities

Tb Support In Swaziland
Goal 3

Share information and resources

LEARN MORE

“REVIVE plays a key role in promoting scientific collaboration and provision of advanced education on antimicrobial R&D and AMR.”

 

– Prof. Angela Dramowski, Professor, Head of Clinical Unit: General Paediatrics, Tygerberg Hospital, Department of Paediatrics and Child Health, Stellenbosch University

Chemistry Analyzer

Current activities

Current activities

REVIVE WEBINARS

Educational webinars on topics related to antimicrobial drug discovery and development

 

AMR DISCUSSIONS

Panel discussions about various topics related to antimicrobial resistance

 

CONFERENCES

Freely available recordings of the GARDP co-organized Antimicrobial Chemotherapy Conferences, plus recordings of co-organised bootcamps and symposia at leading international conferences on AMR

 

ANTIMICROBIAL VIEWPOINTS

Experts in different areas of antimicrobial resistance share their knowledge and opinions about the status and future challenges of this field

ANTIMICROBIAL ENCYCLOPAEDIA

Short definitions of relevant terms in the field of antimicrobial drug discovery, research & development, and AMR

 

AntibioticDB 

The first free, open-access database of antibacterial compounds, including discontinued agents, drugs under pre-clinical development and those in clinical trials. 

 

ANTIMICROBIAL LIBRARY

Explore all the resources offered by REVIVE, as well as links to external resources relevant to antimicrobial R&D

Milestones

  • 75+ webinars since REVIVE was created in 2018
  • 14000+ live webinar participants
  • 8.6/10 average webinar rating
  • 65+ Antimicrobial Viewpointarticles
  • 280+ encyclopaedia entries
  • 83 partners
Revive Revive

To learn more 

Visit REVIVE
Group 1gardp Revive